ID1 Randomised Prospective Study Comparing Cost-Effectiveness of Teicoplanin and Vancomycin As Second-Line Empiric Therapy for Infection in Neutropenic Patients
Abstract
Authors
A Dominguez-Gil M Prez L Santos JF San Miguel L Vzquez P Vilches N Gutierrez R Garca-Siaz D Caballero